{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:43:56Z","timestamp":1792021436884,"version":"4.4.0"},"reference-count":31,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Hum Factors"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Digital health studies using electronic patient-reported outcomes (ePROs) and wearables bring new challenges, including the need for participants to consistently provide trial data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to characterize the engagement, protocol adherence, and data completeness among participants with rheumatoid arthritis enrolled in the Digital Tracking of Arthritis Longitudinally (DIGITAL) study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants were invited to participate in this app-based study, which included a 14-day run-in and an 84-day main study. In the run-in period, data were collected via the ArthritisPower mobile app to increase app familiarity and identify the individuals who were motivated to participate. Successful completers of the run-in period were mailed a wearable smartwatch, and automated and manual prompts were sent to participants, reminding them to complete app input or regularly wear and synchronize devices, respectively, during the main study. Study coordinators monitored participant data and contacted participants via email, SMS text messaging, and phone to resolve adherence issues per a priori rules, in which consecutive spans of missing data triggered participant contact. Adherence to data collection during the main study period was defined as providing requested data for &gt;70% of 84 days (daily ePRO, \u226580% daily smartwatch data) or at least 9 of 12 weeks (weekly ePRO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 470 participants expressing initial interest, 278 (59.1%) completed the run-in period and qualified for the main study. Over the 12-week main study period, 87.4% (243\/278) of participants met the definition of adherence to protocol-specified data collection for weekly ePRO, and 57.2% (159\/278) did so for daily ePRO. For smartwatch data, 81.7% (227\/278) of the participants adhered to the protocol-specified data collection. In total, 52.9% (147\/278) of the participants met composite adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with other digital health rheumatoid arthritis studies, a short run-in period appears useful for identifying participants likely to engage in a study that collects data via a mobile app and wearables and gives participants time to acclimate to study requirements. Automated or manual prompts (ie, \u201cIt\u2019s time to sync your smartwatch\u201d) may be necessary to optimize adherence. Adherence varies by data collection type (eg, ePRO vs smartwatch data).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>International Registered Report Identifier (IRRID)<\/jats:title>\n                    <jats:p>RR2-10.2196\/14665<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/44034","type":"journal-article","created":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T18:38:40Z","timestamp":1692556720000},"page":"e44034","source":"Crossref","is-referenced-by-count":14,"title":["Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-6476","authenticated-orcid":false,"given":"William B","family":"Nowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8907-8976","authenticated-orcid":false,"given":"Jeffrey R","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8466-4323","authenticated-orcid":false,"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7365-4801","authenticated-orcid":false,"given":"Fenglong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-1022","authenticated-orcid":false,"given":"Laura","family":"Stradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8005-912X","authenticated-orcid":false,"given":"David","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2615-4940","authenticated-orcid":false,"given":"Kelly","family":"Gavigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9345-7048","authenticated-orcid":false,"given":"Jessica","family":"Boles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2075-4470","authenticated-orcid":false,"given":"Cassie","family":"Clinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1936-2197","authenticated-orcid":false,"given":"Ilya","family":"Lipkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3889-9034","authenticated-orcid":false,"given":"Shilpa","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9610-8838","authenticated-orcid":false,"given":"Amy","family":"Calvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-8477","authenticated-orcid":false,"given":"Virginia S","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1460"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5169"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23752"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02272-2"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2196\/14368"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-015-0027-x"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.7863"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005113.pub2"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004525.pub2"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007356.pub2"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.9656"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez207"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000493277"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2196\/14665"},{"issue":"suppl 9","key":"ref15","volume":"70","author":"Nowell, WB","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000506860"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1996.tb02080.x"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"Friedman, J","year":"2010","journal-title":"J Stat Softw"},{"key":"ref19","unstructured":"Drug therapy for rheumatoid arthritis in adults: an update. Agency for healthcare research and qualityAgency for Healthcare Research and Quality20122022-11-30https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK97388\/pdf\/Bookshelf_NBK97388.pdf"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012591"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-021-00418-3"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05633-4"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000455"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016060"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/s20174797"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.06.015"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24083"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200486"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0224-8"},{"key":"ref30","unstructured":"Medicare program; CY 2022 payment policies under the physician fee schedule and other changes to part B payment policies; Medicare shared savings program requirements; provider enrollment regulation updates; and provider and supplier prepayment and post-payment medical review requirementsFederal Register20222022-11-30https:\/\/www.federalregister.gov\/documents\/2021\/11\/19\/2021-23972\/medicare-program-cy-2022-payment-policies-under-the-physician-fee-schedule-and-other-changes-to-part"},{"key":"ref31","unstructured":"Medicare program; revisions to payment policies under the physician fee schedule and other revisions to part B for CY 2019; Medicare shared savings program requirements; quality payment program; Medicaid promoting interoperability program; quality payment program-extreme and uncontrollable circumstance policy for the 2019 MIPS payment year; provisions from the Medicare shared savings program-accountable care organizations-pathways to success; and expanding the use of telehealth services for the treatment of opioid use disorder under the Substance Use-Disorder Prevention That Promotes opioid recovery and treatment (SUPPORT) for patients and communities actFederal Register2023-10-19https:\/\/www.federalregister.gov\/documents\/2018\/11\/23\/2018-24170\/medicare-program-revisions-to-payment-policies-under-the-physician-fee-schedule-and-other-revisions"}],"container-title":["JMIR Human Factors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/humanfactors.jmir.org\/2023\/1\/e44034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:47:26Z","timestamp":1782841646000},"score":1,"resource":{"primary":{"URL":"https:\/\/humanfactors.jmir.org\/2023\/1\/e44034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2196\/44034","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.44034","asserted-by":"object"}]},"ISSN":["2292-9495"],"issn-type":[{"value":"2292-9495","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}